Susceptibility of bacteria isolated from acute gastrointestinal infections to rifaximin and other antimicrobial agents in Mexico

Bacterial resistance may hamper the antimicrobial management of acute gastroenteritis. Bacterial susceptibility to rifaximin, an antibiotic that achieves high fecal concentrations (up to 8,000μg/g), has not been evaluated in Mexico. To determine the susceptibility to rifaximin and other antimicrobia...

Full description

Saved in:
Bibliographic Details
Published in:Revista de gastroenterología de México 2016-01, Vol.81 (1), p.3-10
Main Authors: Novoa-Farías, O, Frati-Munari, A C, Peredo, M A, Flores-Juárez, S, Novoa-García, O, Galicia-Tapia, J, Romero-Carpio, C E
Format: Article
Language:eng ; spa
Subjects:
Acute Disease
Anti-Bacterial Agents - pharmacology
Bacterial Infections - microbiology
Gastroenteritis - microbiology
Humans
Mexico
Microbial Sensitivity Tests
Rifamycins - pharmacology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bacterial resistance may hamper the antimicrobial management of acute gastroenteritis. Bacterial susceptibility to rifaximin, an antibiotic that achieves high fecal concentrations (up to 8,000μg/g), has not been evaluated in Mexico. To determine the susceptibility to rifaximin and other antimicrobial agents of enteropathogenic bacteria isolated from patients with acute gastroenteritis in Mexico. Bacterial strains were analyzed in stool samples from 1,000 patients with diagnosis of acute gastroenteritis. The susceptibility to rifaximin (RIF) was tested by microdilution (
ISSN:0375-0906
DOI:10.1016/j.rgmx.2015.07.003